Zach Amdurer
Physician Assistant · Wheat Ridge, CONPI 1679008940
Payments from drug & device makers
Across 278 payments — averaging $18.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$944
- AstraZeneca$804
- Boehringer Ingelheim$382
- Lilly USA, LLC$280
- Amgen$258
- Medtronic$239
- plus $2K from 33 others
What the payments were for
- Food & beverage$4,96499%
- Education$701%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 64 | $944 |
| AstraZeneca | 32 | $804 |
| Boehringer Ingelheim | 19 | $382 |
| Lilly USA, LLC | 22 | $280 |
| Amgen(2 entities) | 12 | $258 |
| Medtronic | 8 | $239 |
| Pfizer | 14 | $236 |
| Novartis | 9 | $193 |
| GSK | 14 | $174 |
| Johnson & Johnson | 8 | $155 |
| Novo Nordisk | 9 | $132 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $129 |
| Biohaven Pharmaceuticals, Inc. | 7 | $124 |
| Amarin Pharma, Inc. | 7 | $123 |
| Astellas Pharma US Inc | 4 | $82 |
| Merck | 5 | $80 |
| Nestle Healthcare Nutrition Inc. | 4 | $77 |
| Esperion Therapeutics, Inc. | 3 | $74 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $48 |
| Eisai Inc. | 3 | $47 |
| Bayer | 3 | $47 |
| Grifols USA, LLC | 2 | $38 |
| Optinose US, Inc. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| Biogen | 2 | $32 |
| Sanofi-aventis U.S. LLC | 2 | $29 |
| Exact Sciences | 1 | $24 |
| VBI Vaccine (delaware) Inc. | 1 | $22 |
| Si-bone, Inc. | 1 | $22 |
| Corcept Therapeutics | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Sanofi Pasteur Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
| Neos Therapeutics, LP | 1 | $16 |
| Tactile Systems Technology Inc | 1 | $13 |
| Coopersurgical, Inc. | 1 | $13 |
| Impel Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,034 in reported general payments places this provider in the 90th percentile of 2,849 physician assistant providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 63 | $73,923 |
| JardianceEmpagliflozin | 49 | $61,442 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 63 | $47,315 |
| EliquisApixaban | 40 | $32,523 |
| XareltoRivaroxaban | 28 | $23,359 |
| OzempicSemaglutide | 19 | $21,741 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 13 | $21,188 |
| MounjaroTirzepatide | 17 | $17,897 |
| FarxigaDapagliflozin Propanediol | 15 | $16,460 |
| JanuviaSitagliptin Phosphate | 11 | $14,427 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 12 | $9,300 |
| Invokamet XrCanagliflozin/Metformin Hcl | 13 | $8,133 |
| Xigduo XrDapaglifloz Propaned/Metformin | 12 | $7,956 |
| MovantikNaloxegol Oxalate | 13 | $5,420 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 36 | $4,958 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $280 | $91,82080 claims |
| Boehringer IngelheimJardiance, Synjardy Xr | $382 | $82,63062 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $174 | $61,41586 claims |
| PfizerEliquis | $236 | $32,52340 claims |
| Johnson & JohnsonXarelto | $155 | $23,35928 claims |
| Novo NordiskOzempic | $132 | $21,74119 claims |
| AstraZenecaFarxiga | $804 | $16,46015 claims |
| MerckJanuvia | $80 | $14,42711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,849 physician assistant providers in Colorado.
Other physician assistant in Wheat Ridge
- Donald MooreEnglewood$246K
- Neekan AeiniGreenwood Village$234K
- Korby HowellCortez$182K
- Heather FinlaysonLittleton$180K
- Kristen LervikDenver$131K
- Marissa Moritz-GuzikLouisville$94K
- Clayton LabaumeDurango$87K
- Emily FrischDenver$79K
- Daniel HumerLone Tree$69K
- Christine ZerrLittleton$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.